Lupus (SLE): vizsgálatok itt: Egyesült Államok
100 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.
- 1. fázisTaking peopleA Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
- Where
- Anniston, Clearwater, Greenacres City, Houston, Jackson, Kissimmee, Miami, Orland Park, Plantation, Red Oak, Tampa, Tustin
- Életkor
- 18 év to 75 év
- People
- 30 worldwide
- Run by
- AbbVie
See details and how to joinNCT07607964 - 1. fázisTaking peopleA Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
- Where
- Anniston, Birmingham, Chapel Hill, Iowa City, La Jolla, Omaha, Sacramento
- Életkor
- 18 év to 70 év
- People
- 72 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06916806 · EU 2024-519015-34-00 - No phaseTaking peopleLupus Nephritis Care Pathway
- Where
- Durham
- Életkor
- 18 év and over
- People
- 25
- Run by
- Duke University
See details and how to joinNCT07783152 - 3. fázisCsak meghívásosA Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus Erythematosus
- Where
- Atlanta, Avondale, Beckley, Bellaire, Beverly Hills, Birmingham, Brandon, Canton, Charlotte, Chicago, Colleyville, Denver, Detroit, Gainesville, Glendale, Hagerstown, Hershey, Hopkinsville, Idaho Falls, Jackson, Lake Charles, La Palma, Las Vegas, Manhasset, Miami, New Orleans, New York, Ormond Beach, Phoenix, Plantation, San Leandro, Tampa, Tucson
- Életkor
- 16 év and over
- People
- 760 worldwide
- Run by
- UCB Biopharma SRL
See details and how to joinNCT04976322 · EU 2023-506368-14-00 - 1. fázisNot yet taking people in Egyesült ÁllamokA Study of BMS-986553 in Participants With Refractory Autoimmune Diseases
- Where
- Ann Arbor, Great Neck, Morristown, Newport Beach, Omaha, Philadelphia, Saint Paul, Salt Lake City, Seattle, Worcester
- Életkor
- 18 év and over
- People
- 60 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07873931 - No phaseNot yet taking people in Egyesült ÁllamokHome-Based High-Intensity Interval Training in Systemic Lupus Erythematosus
- Where
- Birmingham
- Életkor
- 18 év to 65 év
- People
- 20
- Run by
- University of Alabama at Birmingham
See details and how to joinNCT07716462 - 1/2. fázisTaking peopleRESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
- Where
- Atlanta, Boston, Chapel Hill, Charleston, Chicago, Gainesville, Houston, Jacksonville, Kansas City, Minneapolis, New Haven, New York, Orange, Philadelphia, Rochester, Sacramento, Worcester
- Életkor
- 12 év to 65 év
- People
- 28 worldwide
- Run by
- Cabaletta Bio
See details and how to joinNCT06121297 · EU 2023-507613-10-01 - 1. fázisTaking peopleTesting an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Where
- Atlanta, Baltimore, Bethesda, Birmingham, Boston, Chicago, City of Saint Peters, Columbus, Creve Coeur, Dallas, Detroit, Fairway, Fort Worth, Hays, Houston, Kansas City, Lawrence, Lee's Summit, Lexington, Mineola, New Brunswick, New Haven, New York, North Kansas City, Olathe, Overland Park, Palo Alto, Philadelphia, Pittsburg, Pittsburgh, Richardson, Richmond, Sacramento, Salina, Salt Lake City, St Louis, Topeka, Washington D.C., Westwood
- Életkor
- 18 év and over
- People
- 300 worldwide
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT03816345 - 3. fázisCsak meghívásosA Study to Learn More About the Long-Term Safety of Litifilimab (BIIB059) Injections and it's Effects on Symptoms in Adults With Systemic Lupus Erythematosus (SLE)
- Where
- Allen, Aurora, Austin, Aventura, Avon Park, Baytown, Beverly Hills, Brooklyn, Charlotte, Cincinnati, Clearwater, Colleyville, Cooper City, DeBary, Flint, Gainesville, Houston, Humble, Huntington Beach, Jackson, Katy, Margate, Memphis, Middleburg Heights, Mission Hills, Orlando, Phoenix, Rochester Hills, Salisbury, San Antonio, Seattle, St Louis, Tampa, The Woodlands, Upland, Washington D.C., Worcester
- Életkor
- 18 év and over
- People
- 864 worldwide
- Run by
- Biogen
See details and how to joinNCT05352919 · EU 2023-505635-13-00 - 2. fázisTaking peopleA Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
- Where
- Aurora, Boston, Cleveland, Great Neck, Hawthorne, Hialeah, Homestead, Houston, Miami, New Orleans, New York, Rochester, Scottsdale, Seattle, South Miami
- Életkor
- 18 év to 75 év
- People
- 220 worldwide
- Run by
- Amgen
See details and how to joinNCT06570798 - 2. fázisTaking peopleA Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G
- Where
- Hollywood, Lawrenceville, Orangeburg
- Életkor
- 16 év and over
- People
- 30 worldwide
- Run by
- Akebia Therapeutics
See details and how to joinNCT06419205 - 3. fázisTaking peopleAn Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
- Where
- Bethesda, Chicago, Cincinnati, Cleveland, Columbus, Durham, El Paso, Greenville, Houston, Los Angeles, New Hyde Park, New Orleans, New York, Philadelphia, Phoenix, Portland, Saint Paul, Salt Lake City, The Bronx, Valhalla, Washington D.C.
- Életkor
- 5 év to 17 év
- People
- 100 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05835310 · EU 2022-502289-25-00 - 1. fázisCsak meghívásosA Study of KITE-363 in Participants With Refractory Autoimmune Diseases
- Where
- Duarte, New York, Stanford, Tampa
- Életkor
- 18 év and over
- People
- 52 worldwide
- Run by
- Kite, A Gilead Company
See details and how to joinNCT07038447 - 1/2. fázisTaking peopleCD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus
- Where
- Philadelphia
- Életkor
- 10 év to 29 év
- People
- 24
- Run by
- Children's Hospital of Philadelphia
See details and how to joinNCT06839976 - 2. fázisTaking peopleThe Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE) - IFN-CVD
- Where
- Bethesda
- Életkor
- 18 év to 80 év
- People
- 45
- Run by
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
See details and how to joinNCT05440422 - No phaseTaking peopleAnifrolumab Pregnancy Study
- Where
- Cary
- Életkor
- 18 év to 130 év
- People
- 500
- Run by
- AstraZeneca
See details and how to joinNCT07049653 - 2. fázisTaking peopleTranscutaneous Vagus Nerve Stimulation in SLE
- Where
- Manhasset
- Életkor
- 18 év and over
- People
- 18
- Run by
- Northwell Health
See details and how to joinNCT06987565 - 2. fázisTaking peopleA Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis
- Where
- Chicago, Hawthorne, New Hyde Park, Philadelphia
- Életkor
- 16 év to 70 év
- People
- 20
- Run by
- iCell Gene Therapeutics
See details and how to joinNCT07328581 - 2. fázisTaking peopleVIBRANT: VIB4920 for Active Lupus Nephritis
- Where
- Ann Arbor, Atlanta, Aurora, Charleston, Chicago, Hershey, La Jolla, Los Angeles, Manhasset, Miami, New Haven, New York, Orange, Philadelphia, San Francisco, St Louis
- Életkor
- 18 év and over
- People
- 74
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT05201469 - 4. fázisTaking peopleProspective Registry Investigating Maternal, Infant, and Lactation Outcomes in Anifrolumab Users
- Where
- Las Vegas
- Életkor
- 18 év to 130 év
- People
- 16
- Run by
- AstraZeneca
See details and how to joinNCT06594068 - No phaseTaking peopleHEALTH Home Urinalysis Testing
- Where
- New York
- Életkor
- 18 év and over
- People
- 160
- Run by
- NYU Langone Health
See details and how to joinNCT07823478 - 2. fázisTaking peopleThe Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study
- Where
- Akron, Atlanta, Aurora, Chapel Hill, Charleston, Chicago, Cincinnati, Cleveland, Columbus, Hackensack, Houston, Milwaukee, New York, Salt Lake City, San Francisco, Seattle, St Louis
- Életkor
- 8 év to 20 év
- People
- 105
- Run by
- Children's Hospital Medical Center, Cincinnati
See details and how to joinNCT05538208 - 2. fázisTaking peopleA Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis
- Where
- Beverly Hills, Cooper City, Dallas, Fayetteville, Fontana, Fullerton, Gainesville, Irvine, Miami, Omaha, San Francisco
- Életkor
- 12 év to 70 év
- People
- 53
- Run by
- Fate Therapeutics
See details and how to joinNCT07570862 - 3. fázisCsak meghívásosLong-term Safety and Tolerability of Cenerimod in Adults With Systemic Lupus Erythematosus
- Where
- Aurora, Baytown, Bellaire, Clearwater, DeBary, Houston, Lake Charles, Las Vegas, Miami, Miami Lakes, San Antonio
- Életkor
- 18 év to 75 év
- People
- 680 worldwide
- Run by
- Viatris Innovation GmbH
See details and how to joinNCT06475742 · EU 2024-514354-67-00 - 1/2. fázisTaking peopleA Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
- Where
- Atlanta, Baltimore, Bethesda, Boston, Chapel Hill, Charlotte, Chicago, New York, Richmond, San Francisco, Seattle, Stanford, St Louis, Syracuse, Tampa
- Életkor
- 18 év to 70 év
- People
- 150 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06897930